1. “The protein kinase C (PKC) inhibitors UCN‐01 and flavopiridol(Flavo) significantly enhance the cytotoxic effect of chemotherapy by promoting apoptosis in gastric and breast cancer cells;Schwartz;Proc. ASCO.,1996
2. Parenteral formulation of flavopiridol (NSC‐649890);Dannenfelser;PDA J. Pharm. Sci. Technol.,1995
3. Combined effect of complexation and pH on solubilization;Li;J. Pharm. Sci.,1998
4. Solubilization of ionized and un‐ionized flavopiridol by ethanol and polysorbate 20;Li;J. Pharm. Sci.,1999
5. Evaluation of intravenous flavopiridol formulations;Li;PDA J. Pharm. Sci. Technol.,1999